Global Cancer Imaging System Market Size By Type (Breast Cancer, Lung Cancer), By Application (Hospitals, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Cancer Imaging System Market was valued at USD 9.1 billion in 2023 and is expected to reach USD 15.8 billion by 2031, growing at a CAGR of 7.0% during the forecast period from 2023 to 2031. Cancer imaging systems play a vital role in early detection, accurate diagnosis, staging, and monitoring of cancer, significantly impacting patient outcomes. The rising global cancer incidence, advancements in imaging technologies, and increasing demand for non-invasive diagnostic techniques are driving market expansion. These systems, encompassing modalities such as MRI, CT, PET, and ultrasound, are increasingly integrated with AI and machine learning to enhance diagnostic precision and workflow efficiency.

Drivers:

1. Rising Global Cancer Prevalence:

An increasing number of cancer cases worldwide is the primary driver of the market. Early detection through advanced imaging improves survival rates, prompting governments and healthcare institutions to invest in modern imaging technologies.

2. Technological Advancements in Imaging Modalities:

Continual innovation, such as hybrid imaging systems (PET/CT, PET/MRI), AI-powered image analysis, and contrast-enhanced imaging, is enhancing diagnostic accuracy and driving adoption across healthcare settings.

3. Shift Toward Early Diagnosis and Personalized Treatment:

Healthcare providers are emphasizing early diagnosis to enable targeted and personalized therapies. Imaging systems play a key role in this paradigm, promoting widespread deployment in hospitals and cancer research centers.

Restraints:

1. High Cost of Advanced Imaging Systems:

The high capital and maintenance costs of cancer imaging systems, particularly in resource-limited settings, pose a significant challenge to market penetration.

2. Shortage of Skilled Radiologists:

The effectiveness of cancer imaging technologies depends on the expertise of radiologists. A global shortage of trained imaging professionals can limit the optimal utilization of advanced imaging modalities.

Opportunity:

1. Integration of AI and Machine Learning:

The incorporation of AI algorithms for image analysis and diagnostic decision support offers significant growth potential. AI-enhanced imaging helps reduce interpretation time, increase accuracy, and streamline clinical workflows.

2. Expansion in Emerging Markets:

Rising healthcare investments and awareness of cancer screening in emerging markets such as India, Brazil, and Southeast Asia are opening new avenues for manufacturers to expand their footprint.

Market by System Type Insights:

By system type, the Positron Emission Tomography (PET) Systems segment held the largest share in 2023. The segment’s dominance is attributed to its high sensitivity in detecting metabolic activity of cancer cells, aiding in precise diagnosis and treatment monitoring. Meanwhile, MRI systems are gaining momentum due to their superior soft tissue contrast and non-ionizing radiation advantage.

Market by End-use Insights:

The Hospital segment emerged as the largest end-use category, accounting for over 45% of the market share in 2023. Hospitals continue to be the primary adopters of cancer imaging systems, backed by well-established diagnostic infrastructure and rising inpatient cancer diagnostics. The diagnostic imaging centers segment is anticipated to witness significant growth due to the growing trend of outpatient diagnostic services.

Market by Regional Insights:

North America led the global cancer imaging system market in 2023, driven by advanced healthcare infrastructure, favorable reimbursement policies, and a high prevalence of cancer. However, Asia-Pacific is expected to register the fastest growth during the forecast period, spurred by rising awareness, government screening initiatives, and an expanding middle class investing in preventive healthcare.

Competitive Scenario:

Prominent companies in the global cancer imaging system market include GE HealthCare, Siemens Healthineers, Canon Medical Systems, Koninklijke Philips N.V., Hitachi Ltd., United Imaging Healthcare, Bruker Corporation, and FUJIFILM Holdings Corporation. These firms are actively pursuing strategies such as technological innovation, AI integration, strategic partnerships, and regional expansion to maintain competitive advantage.

Key Market Developments:

2023: GE HealthCare introduced a new AI-driven PET/CT scanner designed to enhance tumor detection with reduced radiation dose.

2024: Siemens Healthineers partnered with a leading oncology center to integrate AI-based decision support tools into MRI workflows for cancer diagnosis.

2025: Canon Medical Systems launched an advanced ultrasound system tailored for real-time oncology applications in outpatient settings.

Scope of Work – Global Cancer Imaging System Market

Report Metric Details

Market Size (2023) USD 9.1 billion

Projected Market Size (2031) USD 15.8 billion

CAGR (2023–2031) 7.0%

Market Segments System Type (MRI, CT, PET, Ultrasound), End-use (Hospitals, Imaging Centers, Research Institutions), Region

Growth Drivers Rising cancer incidence, Technological advancements, Demand for early diagnosis

Opportunities AI integration, Expansion in emerging markets

FAQs:

1) What is the current market size of the Global Cancer Imaging System Market?

The market was valued at USD 9.1 billion in 2023.

2) What is the major growth driver of the Global Cancer Imaging System Market?

The primary growth driver is the rising global prevalence of cancer coupled with demand for early, non-invasive diagnostics.

3) Which is the largest region during the forecast period in the Global Cancer Imaging System Market?

North America held the largest market share in 2023, while Asia-Pacific is projected to experience the fastest growth.

4) Which segment accounted for the largest market share in the Global Cancer Imaging System Market?

The Positron Emission Tomography (PET) Systems segment led by system type in 2023.

5) Who are the key market players in the Global Cancer Imaging System Market?

Key players include GE HealthCare, Siemens Healthineers, Canon Medical Systems, Koninklijke Philips N.V., and FUJIFILM Holdings Corporation.